Coherus BioSciences (CHRS) is a late-stage clinical biologics platform company focused on the global biosimilar market. It is based in Redwood City, CA. Ten other companies are scheduled for the
Full IPO calendar & reports HERE. In order of largest IPO first. (1) Based in Denver, CO,Antero Midstream Partners LP (AM) scheduled a $750 million IPO on NYSE with a market
The Labor Department said Wednesday morning that its Consumer Price Index, a key measure of inflation, was flat in December, lead by a drop in gasoline prices, following a 0.3 percent increase in
Company chart and information is provided by TradingView based on 15-minute-delayed data.
Coherus BioSciences Inc is a United States based biotherapeutics company engaged in developing and commercializing biosimilar therapeutics. The company focuses on process science, analytical characterization, protein production, and clinical-regulatory development. Its pipeline includes Immunology, anti-tumor necrosis factor (Anti-TNF) biosimilar candidates; Ophthalmology biosimilar candidates; and Oncology Biosimilar candidates. Geographically, the group has a business presence in the United States and other countries.
| Website: | www.coherus.com |
| Email: | darrington@coherus.com |
| Main Phone: | +1 650 649-3530 |
| Address: | 333 Twin Dolphin Drive |
| Address 2: | Suite 600 |
| State: | CA |
| City / Town: | Redwood City |
| Country: | US |
| Postal Code: | 94065 |
| Exchange: | NSD |
| CEO: | Dennis M. Lanfear |
| Employees: | 317 |
| NAICS: | Research and Development in Biotechnology (except Nanobiotechnology)(541714) |
Coherus BioSciences (CHRS) is a late-stage clinical biologics platform company focused on the global biosimilar market. It is based in Redwood City, CA. Ten other companies are scheduled for the
Full IPO calendar & reports HERE. In order of largest IPO first. (1) Based in Denver, CO,Antero Midstream Partners LP (AM) scheduled a $750 million IPO on NYSE with a market
The Labor Department said Wednesday morning that its Consumer Price Index, a key measure of inflation, was flat in December, lead by a drop in gasoline prices, following a 0.3 percent increase in
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
